UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4701
CALL
Entegris
ENTG
$23.2B
| $2M | ﹤0.01% |
20,200
| – | – |
|
|
BRSL
4702
PUT
Brightstar Lottery PLC
BRSL
$2.03B
| $2M | ﹤0.01% |
+113,200
| New | +$2.23M |
|
4703
Immunome
IMNM
$2.83B
| $2M | ﹤0.01% |
188,197
+108,957
| +138% | +$1.32M |
|
4704
CTS Corp
CTS
$1.89B
| $1.99M | ﹤0.01% |
37,828
+22,805
| +152% | +$1.19M |
|
4705
RELX
RELX
$62B
| $1.99M | ﹤0.01% |
43,910
+21,953
| +100% | +$1.03M |
|
4706
Lesaka Technologies
LSAK
$420M
| $1.99M | ﹤0.01% |
365,806
+16,596
| +5% | +$86.5K |
|
4707
Kornit Digital
KRNT
$791M
| $1.99M | ﹤0.01% |
64,397
+60,957
| +1,772% | +$1.75M |
|
4708
Latham Group
SWIM
$880M
| $1.99M | ﹤0.01% |
286,297
+244,475
| +585% | +$1.64M |
|
4709
PUT
First Majestic Silver
AG
$9.07B
| $1.99M | ﹤0.01% |
362,300
| – | – |
|
4710
Vivid Seats
SEAT
$85.4M
| $1.99M | ﹤0.01% |
21,479
+19,273
| +874% | +$1.44M |
|
4711
Direxion Daily GOOGL Bull 2X ETF
GGLL
$1.01B
| $1.99M | ﹤0.01% |
43,420
+40,264
| +1,276% | +$1.64M |
|
4712
PUT
Texas Roadhouse
TXRH
$13.7B
| $1.98M | ﹤0.01% |
11,000
| – | – |
|
4713
Clean Energy Fuels
CLNE
$346M
| $1.98M | ﹤0.01% |
790,291
+483,580
| +158% | +$1.37M |
|
|
GHY
4714
PGIM Global High Yield Fund
GHY
$483M
| $1.98M | ﹤0.01% |
160,637
+19,084
| +13% | +$242K |
|
4715
ENI
E
$77.5B
| $1.98M | ﹤0.01% |
72,271
-96,358
| -57% | -$2.82M |
|
|
GTM
4716
PUT
ZoomInfo Technologies
GTM
$1.22B
| $1.98M | ﹤0.01% |
188,100
+93,700
| +99% | +$1M |
|
|
CVAC
4717
DELISTED
CureVac
CVAC
| $1.97M | ﹤0.01% |
576,897
+517,223
| +867% | +$1.49M |
|
4718
Corsair Gaming
CRSR
$1.55B
| $1.96M | ﹤0.01% |
296,977
+202,264
| +214% | +$1.4M |
|
|
GTY
4719
Getty Realty Corp
GTY
$2.07B
| $1.96M | ﹤0.01% |
65,132
-3,973
| -6% | -$126K |
|
4720
Enliven Therapeutics
ELVN
$4.43B
| $1.96M | ﹤0.01% |
87,188
+59,506
| +215% | +$1.54M |
|
4721
Stoke Therapeutics
STOK
$2.11B
| $1.96M | ﹤0.01% |
177,844
+99,532
| +127% | +$1.22M |
|
|
EXK
4722
Endeavour Silver
EXK
$2.83B
| $1.96M | ﹤0.01% |
535,820
+419,363
| +360% | +$1.85M |
|
4723
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$244M
| $1.96M | ﹤0.01% |
48,903
+1,242
| +3% | +$55.4K |
|
|
EFT
4724
Eaton Vance Floating-Rate Income Trust
EFT
$288M
| $1.96M | ﹤0.01% |
152,498
-31,129
| -17% | -$411K |
|
4725
CALL
Virgin Galactic
SPCE
$398M
| $1.95M | ﹤0.01% |
332,333
| – | – |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.